Evidence map›Paper›PMID 36625603›Full record

ArticleMicrobiology spectrum2023

Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations.

Katja Spiess, Vithiagaran Gunalan, Ellinor Marving, Sofie Holdflod Nielsen, Michelle G P Jørgensen, Anna S Fomsgaard, Line Nielsen, Alonzo Alfaro-Núñez, Søren M Karst, Danish COVID-19 Genome Consortium (DCGC) and 9 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Katja Spiess *Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-2388-4617
Vithiagaran Gunalan *Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Ellinor MarvingDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Sofie Holdflod NielsenTest Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
Michelle G P JørgensenTest Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
Anna S FomsgaardDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Line NielsenTest Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
Alonzo Alfaro-NúñezDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-4050-5041
Søren M KarstDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Danish COVID-19 Genome Consortium (DCGC)
Shila MortensenDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Morten RasmussenDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Ria LassaunièreDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Maiken Worsøe RosenstierneQlife ApS Symbion, Copenhagen, Denmark.
Charlotta PolacekDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Jannik FonagerDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Arieh S CohenTest Center Denmark, Statens Serum Institut, Copenhagen, Denmark.
Claus NielsenDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Anders FomsgaardDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Statens Serum Institut · DKQuality of Life Research Center · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) increase transmission, disease severity, and immune evasion and facilitate zoonotic or anthropozoonotic infections. Four such mutations, ΔH69/V70, L452R, E484K, and N501Y, occurred in the SARS-CoV-2 spike glycoprotein in combinations that allow the simultaneous detection of VOCs. Here, we present two flexible reverse transcription-quantitative PCR (RT-qPCR) platforms for small- and large-scale screening (also known as variant PCR) to detect these mutations and schemes for adapting the platforms to future mutations. The large-scale RT-qPCR platform was validated by pairwise matching of RT-qPCR results with whole-genome sequencing (WGS) consensus genomes, showing high specificity and sensitivity. Both platforms are valuable examples of complementing WGS to support the rapid detection of VOCs. Our mutational signature approach served as an important intervention measure for the Danish public health system to detect and delay the emergence of new VOCs.

Indexed as

COVID-19SARS-CoV-2HumansMutationPolymerase Chain ReactionReverse Transcriptionlarge-scale screeningnational surveillance programnational surveillance systemRT-qPCR platformsSARS-CoV-2signature mutationsvariant of concernvariant PCRvariants of concernwhole-genome sequencing

Identifiers

PMID36625603
PMCPMC9927487
OpenAlexW4315435455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.